Nitrile Glove Shortage Is Here — Stock Up Before Prices Spike

The Geopolitical Context

There has been an ongoing US-Iran (and Israel-Iran) conflict since early 2026. Iran has disrupted or asserted control over shipping in the Strait of Hormuz, a critical chokepoint for ~20% of global oil and gas shipments. This includes attacks on vessels, seizures, a partial/effective blockade, and tit-for-tat actions with the US (naval operations, escorts, exchanges of fire).

• Shipping traffic has dropped sharply (some reports of vessels stranded, reduced transits).
• Oil prices have surged (Brent often $100–$110+/barrel range recently, with spikes higher), driven by uncertainty even if not a total shutdown.

Ceasefire talks and pauses are happening but remain fragile, with ongoing tensions.

Impact on Nitrile Gloves

Nitrile gloves are made from nitrile butadiene rubber (NBR) and related petrochemicals (e.g., butadiene, derived from oil/naphtha refining). Disruptions in oil supply chains have spiked raw material costs:

• Raw material costs up significantly (reports of butadiene surges of 150%+ in some periods).
• Glove prices up ~40% globally, with manufacturers passing on 40–50%+ cost increases.
• One major Malaysian manufacturer (WRP Asia Pacific) has shut down operations, laying off ~1,400 workers, citing exactly these energy/petrochemical supply disruptions from the conflict.

Malaysia (along with other Southeast Asian producers like Thailand/Indonesia) is a top global glove maker. Supply chains are feeling the pressure.

US Vulnerability

The US imports the vast majority of its medical gloves, with heavy reliance on a few countries (primarily Malaysia, Thailand, China, etc.). Reports confirm ~80–90% of PPE and a high share (around 87%) of medical gloves from just 3 main sources, with limited domestic production buffer.

Analysts and manufacturers have warned of tightening supply and shortages hitting in May–June 2026 (or Q2 more broadly) as inventories deplete and higher costs/logistics bite.

Bottom Line

This isn't pure hype — it's grounded in real disruptions from the Hormuz situation flowing through to petrochemical-dependent products. Hospitals, labs, food service, and other users are already seeing price hikes, with availability concerns growing. Stock up where practical if you're a heavy user, but expect volatility as diplomacy or military developments shift. The situation could ease with a stable deal, but right now it's painful upstream.